(Q54074169)

English

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

1 reference

based on heuristic

inferred from title

Hiroyuki Kobayashi

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

author name string

Nawano M

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Anai M

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Funaki M

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Kanda A

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Fukushima Y

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Inukai K

7

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Ogihara T

8

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Sakoda H

9

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Onishi Y

10

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Kikuchi M

11

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Yazaki Y

12

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Oka Y

13

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Asano T

14

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

48

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

10

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

1248-1255

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Pharmacological treatment of diabetic patients with cardiovascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Diabetic hypertensive patients: improving their prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Prevention and treatment of the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin resistance and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Hyperinsulinemia, Insulin Resistance and Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Combination of ACE inhibitors and calcium antagonists: a logical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Recycling of insulin-sensitive glucose transporter in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Hormonal regulation of mammalian glucose transport

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Mechanism of activation and function of protein kinase B.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Exercise, glucose transport, and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with phosphatidylinositol 3-kinase in skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990263-9

7 January 2021

Effect of captopril, losartan, and bradykinin on early steps of insulin action

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIAB.46.12.1950

Identifiers

10.1016/S0026-0495(99)90263-9

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

release_36czmuc6abe4jgvrngnk6b3tv4

1 reference

https://api.fatcat.wiki/v0/release/36czmuc6abe4jgvrngnk6b3tv4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10535386

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54074169&oldid=2045251934"